Complex chromosome 4, 9, and 22 rearrangement in a patient presenting with AML-FAB M2

Cancer Genetics and Cytogenetics

Volumn 93, Issue 2, 1997, Pages 119-124

  Martin, E S ^a   Joseph, A ^a   Ahmad, M A ^a   Borgaonkar, D S ^a   Martin, S E ^a  

^a MEDICAL CENTER OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW CELL; CASE REPORT; CHROMOSOME 22Q; CHROMOSOME 4P; CHROMOSOME 9Q; CHROMOSOME REARRANGEMENT; CYTOGENETICS; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 4; CHROMOSOMES, HUMAN, PAIR 9; COMBINED MODALITY THERAPY; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; PHILADELPHIA CHROMOSOME; TRANSLOCATION, GENETIC;

EID: 0030992411     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00187-2     Document Type: Article

References (33)

1. Nowell PC, Hungerford DA (1960): A minute chromosome in human chronic granulocytic leukemia. Science 132:1497.
2. Rowley JD (1973): A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290-293.
3. Kantarjian H, Deiseeroth A, Kurzrock R, Estrov Z, Talpaz M (1993): Chronic myelogenous leukemia: A concise update. Blood 82:691-703.
4. Kantarjian H, Talpaz M, Estey E, Ku S, Kurzrock R (1994): What is the contribution of molecular studies to the diagnosis of BCR-ABL-positive disease in adult acute leukemia? Am J Med 96:133-138.
5. Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D (1986): The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science 233:212-214.
6. Kurzrock R, Kloetzer WS, Talpaz M, Blick M, Walters R, Arlinghaus RB, Gutterman JU (1987): Identification of molecular variants of p210 bcr-abl in chronic myelogenous leukemia. Blood 70:233-236.
7. Kurzrock R, Shtalrid M, Romero P, Kloetzer WS, Talpas M, Trujillo JM, Blick M, Beran M, Gutterman JU (1987): A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature 325:631-635.
8. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP (1988): Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 85:5698-5702.
9. Denny CT, Shah NP, Ogden S, Willman C, McConnell T, Grist W, Carroll A, Witte ON (1989): Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci USA 86:4254-4258.
10. Clark SS, McLaughlin J, Grist WM, Champlin R, Witte ON (1987): Unique forms of the abl tyrosine kinase distinguish Phi-positive CML from Phi-positive ALL. Science 235:85-88.
11. Lugo TG, Pendergast AM, Muller AJ, Witte ON (1990): Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079-1082.
12. Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N (1991): Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene. Mol Gel Biol 11:4710-4716.
13. Mitelman F (1994): Catalog of Chromosome Aberrations in Cancer, 5th Ed. Wiley-Liss Publishing, New York.
14. Dube I, Dixon J, Beckett T, Grossman A, Weinstein M, Benn P, McKeithan T, Norman C, Pinkerton C, Pinkerton P (1989): Locations of breakpoints within the major breakpoint cluster region (bcr) in 33 patients with bcr rearrangement-positive chronic myeloid leukemia (CML) with complex or absent Philadelphia chromosomes. Genes Chromosom Cancer 1:106-111.
15. Zaccaria A, Testoni N, Tassinari A, Celso B, Rassool F, Saglio G, Guerrasio A, Rosti G, Tura S (1989): Cytogenetic and molecular studies in patients with chronic myeloid leukemia and variant Philadelphia translocations. Cancer Genet Cytogenet 42:191-201.
16. Sessarego M, Fugazza G, Canepa L, Bacigalupo A, Bruzzone R, Patrone F (1995): Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. Leuk Res 19:921-925.
17. Przepiorka D, Thomas ED (1988): Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia. Bone Marrow Transplant 3:113-119.
18. Blick M, Romero P, Talpaz M, Kurzrock R, Shtalrid M, Andersson B, Trujillo J, Beran M, Gutterman J (1987): Molecular characteristics of chronic myelogenous leukemia in blast crisis. Cancer Genet Cytogenet 27:349-356.
19. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW (1995): The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. Leukemia 9:628-633.
20. Hughes TP, Morgan GJ, Martiat P, Goldman JM (1991): Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood 77:874-878.
21. Pederson-Bjergaard J, Rowley JD (1994): The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780-2786.
22. Bloomfield CD, Lawrence D, Arthur DC, Berg DT, Schiffer CA. Mayer RJ (1994): Curative impact of intensification with high dose cytarabine (HiDAC) in acute myeloid leukemia (AML) varies by cytogenetic group. Blood 84:111 (abstract).
23. Nichols J, Nimer SD (1992): Transcription factors, translocations, and leukemia. Blood 80:2953-2963.
24. Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R. (1995): allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659-1665.
25. London B, Pinkerton PH, Senn JS (1986): A new translocation in chronic myeloid leukemia-t(4;9;22)-resulting in a masked Philadelphia chromosome. Cancer Genet Cytogenet 20:5-9.
26. Zhang J, Meltzer P, Jenkins R, Guan XY, Trent J (1993): Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia. Blood 81:3365-3371.
27. Kurzrock R, Shtalrid M, Talpaz M, Kloetzer WS, Gutterman JU (1987): Expression of c-abl in Philadelphia-positive acute myelogenous leukemia, Blood 70:1584-1588.
28. Hirsch-Ginsberg C, Childs C, Chang KS, Beran M, Cork A, Reuben J, Freireich EJ, Chang LC, Bollum FJ, Trujillo J, Stass SA (1988): Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemia. Blood 71:186-195.
29. Tien HF, Wang CH, Chuang SM, Lee FY, Liu MC, Chen YC, Shen MC, Lin DT, Lin KH, Lin KS (1992): Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis. Leukemia 6:907-914.
30. Pui CH, Raimondi SC, Head DR, Schell MJ, Rivera GK, Mirro J Jr, Crist WM, Behm FG (1991): Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 78:1327-1337.
31. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N (1995): BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood 86:4603-4611.
32. Dow LW, Tachibana N, Raimondi SC, Lauer SJ, Witte ON, Clark SS (1989): Comparative biochemical and cytogenetic studies of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and other 22q11 variants. Blood 73:1291-1297.
33. Xiao H, Baer MR, Block AW, Sait SN, Kakati S (1993): Deletion of chromosome 22 without bcr rearrangement and without juxtaposition of c-abl in a case of acute myeloid leukemia. Cancer Genet Cytogenet 67:141-144.